Study shines new light on programmed cell death

12th August, 2016 A form of regulated cell death known as necroptosis – and its role in health and disease – is the topic of new research by Walter and Eliza Hall Institute scientists. An international team of…

Read More

Medtech Trade Mission Going Ahead – Limited Places Still Available!

BioMelbourne Network, on behalf of the State Government of Victoria, is leading a major Medtech Mission to the United States including AdvaMed 2016 – the largest annual medical technology conference on the US calendar. There are still limited…

Read More

BioMelbourne Network Members Invited to Meet with International Medtronic Diabetes Representative

US based Medtronic representative, Dr Huzefa Neemuchwala, will be in Melbourne this month.  BioMelbourne Network member organisations are invited to meet with Dr Neemuchwala. Interested organisations, please contact Dr Krystal Evans on 9667 6161 Dr Huzefa Neemuchwala, PhD MBA,…

Read More

FULLY BOOKED – Free Seminar with Dr Gerald Chan – The Role of Universities in the Innovation Ecosystem

THIS SEMINAR IS FULLY BOOKED The BioMelbourne Network and Biomedical Research Victoria present international guest speaker, Dr Gerald Chan, CEO, Morningside, USA Free Seminar:  The Role of Universities in the Innovation Ecosystem With Australia’s changing economy, the role of universities…

Read More

10 year sector competitiveness plan for Medical Technologies and Pharmaceuticals

August 2016 We want to know if we’ve got it right, said Sue MacLeman, CEO of MTPConnect at the launch of the 10 year Sector Competitiveness Plan – which is still in draft form. The plan outlines seven…

Read More

Breakthrough lung cancer drug discovery by Melbourne researchers

26th July, 2016 A BREAKTHROUGH discovery has opened up a potential new drug to stop lung cancer and emphysema as well as detecting the killer diseases much sooner. Researchers from Melbourne’s Hudson Institute of Medical Science have identified…

Read More

Monash part of world-first clinical trial for lymphoma patients

26th July, 2016 A novel therapy for aggressive lymphoma is being tested in a world-first clinical trial at the Monash Health Translation Precinct (MHTP).In early 2015, researchers at Monash University and Peter MacCallum Cancer Centre showed the novel…

Read More

Burnet Institute and ARTES join forces to develop novel hepatitis C vaccine

27th July, 2016 The Melbourne based Burnet Institute and ARTES Biotechnology announce they have joined forces to develop a novel, effective vaccine to prevent transmission of hepatitis C virus (HCV). An HCV vaccine is urgently needed to prevent…

Read More


News & opinion

Member Directory